Leveraging the power of iPS cell technology to study myeloid neoplasm

byKyoto UniversityCredit:British Journal of Haematology(2024). DOI: 10.1111/bjh.19720Using iPS cells generated from a patient with a myeloid neoplasm caused by a rare chromosomal rea

Updated on: September 27,2024

Leveraging the power of iPS cell technology to study myeloid neoplasm

byKyoto UniversityCredit:British Journal of Haematology(2024). DOI: 10.1111/bjh.19720Using iPS cells generated from a patient with a myeloid neoplasm caused by a rare chromosomal rea

Updated on:September 27,2024

Most detailed atlas to date of human blood stem cells could guide future leukemia care

byCincinnati Children's Hospital Medical CenterA large team of scientists led by experts at Cincinnati Children's has published the world's most detailed "atlas" of the man

Updated on: March 30,2024

Most detailed atlas to date of human blood stem cells could guide future leukemia care

byCincinnati Children's Hospital Medical CenterA large team of scientists led by experts at Cincinnati Children's has published the world's most detailed "atlas" of the man

Updated on:March 30,2024

Largest-ever genetic study of prostate cancer in men of African descent finds new risk factors for the disease

by Keck School of Medicine of USCCredit: Unsplash/CC0 Public DomainProstate cancer takes a greater toll on Black men than on men of other races. In the United States, one in six Black men will ge

Updated on: January 30,2024

Largest-ever genetic study of prostate cancer in men of African descent finds new risk factors for the disease

by Keck School of Medicine of USCCredit: Unsplash/CC0 Public DomainProstate cancer takes a greater toll on Black men than on men of other races. In the United States, one in six Black men will ge

Updated on:January 30,2024

Taxane-induced peripheral neuropathy in breast cancer: Frequent, clinically significant, and worse with paclitaxel

by SWOG Cancer Research NetworkCredit: Unsplash/CC0 Public DomainChemotherapy-induced peripheral neuropathy (CIPN)—nerve pain, tingling, or numbness in the hands or feet—is a common side effect of cer

Updated on: January 22,2024

Taxane-induced peripheral neuropathy in breast cancer: Frequent, clinically significant, and worse with paclitaxel

by SWOG Cancer Research NetworkCredit: Unsplash/CC0 Public DomainChemotherapy-induced peripheral neuropathy (CIPN)—nerve pain, tingling, or numbness in the hands or feet—is a common side effect of cer

Updated on:January 22,2024

Discovery boosts the potential of new cancer-fighting drugs

by The Scripps Research InstituteCancer cell during cell division. Credit: National Institutes of HealthScientists at Scripps Research have uncovered a critical feature that a promising new class

Updated on: February 23,2024

Discovery boosts the potential of new cancer-fighting drugs

by The Scripps Research InstituteCancer cell during cell division. Credit: National Institutes of HealthScientists at Scripps Research have uncovered a critical feature that a promising new class

Updated on:February 23,2024

First line immunotherapy combination fails to improve overall survival in lung cancer

by European Society for Medical OncologyStudy author Dr Naiyer Rizvi, director of thoracic oncology and immunotherapeutics, Columbia University Medical Center, New York, US. Credit: © European So

Updated on: May 23,2024

First line immunotherapy combination fails to improve overall survival in lung cancer

by European Society for Medical OncologyStudy author Dr Naiyer Rizvi, director of thoracic oncology and immunotherapeutics, Columbia University Medical Center, New York, US. Credit: © European So

Updated on:May 23,2024

Free tattoos give hope for Dutch breast cancer survivors

Flowers and butterflies surround the scars left by the removal of Jacqueline van Schaik's breasts, thanks to a new tattoo the cancer survivor says she treasures."It's magnificent," e

Updated on: January 02,2024

Free tattoos give hope for Dutch breast cancer survivors

Flowers and butterflies surround the scars left by the removal of Jacqueline van Schaik's breasts, thanks to a new tattoo the cancer survivor says she treasures."It's magnificent," e

Updated on:January 02,2024

Identifying key markers in pancreatic cancer progression using a new analysis pipeline

byJohns Hopkins UniversityNovel computational pipeline developed by Johns Hopkins Kimmel Cancer Researchers to identify early molecular and cellular progression to pancreatic ductal adenocarcino

Updated on: September 10,2024

Identifying key markers in pancreatic cancer progression using a new analysis pipeline

byJohns Hopkins UniversityNovel computational pipeline developed by Johns Hopkins Kimmel Cancer Researchers to identify early molecular and cellular progression to pancreatic ductal adenocarcino

Updated on:September 10,2024

Tracking radiation treatment in real time promises safer, more effective cancer therapy

by Jim Lynch,University of MichiganiRAI system schematic and the experimental setup. a, 3D schematic of the iRAI system for mapping the dose deposition in a patient during RT delivery. b, CAD vi

Updated on: January 04,2024

Tracking radiation treatment in real time promises safer, more effective cancer therapy

by Jim Lynch,University of MichiganiRAI system schematic and the experimental setup. a, 3D schematic of the iRAI system for mapping the dose deposition in a patient during RT delivery. b, CAD vi

Updated on:January 04,2024

Some cervical cancer screening strategies more cost-effective

(HealthDay)—A cervical cancer screening strategy that involves cytologic testing every three years from ages 21 to 29 years and then continuing cytologic testing or switching to low-cost high-risk hum

Updated on: May 21,2024

Some cervical cancer screening strategies more cost-effective

(HealthDay)—A cervical cancer screening strategy that involves cytologic testing every three years from ages 21 to 29 years and then continuing cytologic testing or switching to low-cost high-risk hum

Updated on:May 21,2024

Examining resistance to immunotherapy in ovarian cancer

byMemorial Sloan Kettering Cancer CenterTME of HGSOC at single-cell resolution.a, Overview of the MSK SPECTRUM cohort and specimen collection workflow.b, UMAP plot of cells profiled

Updated on: December 28,2023

Examining resistance to immunotherapy in ovarian cancer

byMemorial Sloan Kettering Cancer CenterTME of HGSOC at single-cell resolution.a, Overview of the MSK SPECTRUM cohort and specimen collection workflow.b, UMAP plot of cells profiled

Updated on:December 28,2023

Identifying the underlying causes of ovarian cancer

byCedars-Sinai Medical CenterSimon Gayther, PhD, professor of Biomedical Sciences, and Michelle Jones, PhD, a research scientist in the Center for Bioinformatics and Functional Genomics, led the

Updated on: January 02,2024

Identifying the underlying causes of ovarian cancer

byCedars-Sinai Medical CenterSimon Gayther, PhD, professor of Biomedical Sciences, and Michelle Jones, PhD, a research scientist in the Center for Bioinformatics and Functional Genomics, led the

Updated on:January 02,2024